Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingbo Wu

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Cancer Science|October 25, 2018
Preliminary report of a single-channel applicator in high dose rate afterloading brachytherapy for cervical cancerDan Li, En Wen, Yingjie Zhang, et al.
Optics Express|December 19, 2025
Encryption and decryption applications on conductive films using THz real-time high-resolution imagingWei Zhang, Chen Du, Bowen Tan, et al.
Light, Science & Applications|June 4, 2023
Directional terahertz holography with thermally active Janus metasurfaceBenwen Chen, Shengxin Yang, Jian Chen, et al.
ACS Central Science|March 30, 2026
Target-Centric Multiplexed Screening of an Herbal Extract Identifies a Novel Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist for Cancer ImmunotherapyHongyue Liu, Xinyu Yang, Jingyi Xu, et al.
Cell Reports|May 29, 2026
Targeting EP2/EP4-driven expansion of suppressive VSIG4<sup>high</sup> macrophages overcomes immunotherapy resistance in colorectal cancerYao Zhang, Xinyu Yang, Zhiyuan Cheng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2017
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trialHongru Yang, Xin Chen, Sheng Lin, et al.
Nature Communications|May 25, 2021
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomicsRen-Bo Ding, Ping Chen, Barani Kumar Rajendran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Shukui Qin, Jianming Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 4, 2021
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast CancerPing Chen, Xu Zhang, Renbo Ding, et al.
Nature Immunology|February 5, 2025
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Cancer Science|October 25, 2018
Preliminary report of a single-channel applicator in high dose rate afterloading brachytherapy for cervical cancerDan Li, En Wen, Yingjie Zhang, et al.
Optics Express|December 19, 2025
Encryption and decryption applications on conductive films using THz real-time high-resolution imagingWei Zhang, Chen Du, Bowen Tan, et al.
Light, Science & Applications|June 4, 2023
Directional terahertz holography with thermally active Janus metasurfaceBenwen Chen, Shengxin Yang, Jian Chen, et al.
ACS Central Science|March 30, 2026
Target-Centric Multiplexed Screening of an Herbal Extract Identifies a Novel Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist for Cancer ImmunotherapyHongyue Liu, Xinyu Yang, Jingyi Xu, et al.
Cell Reports|May 29, 2026
Targeting EP2/EP4-driven expansion of suppressive VSIG4<sup>high</sup> macrophages overcomes immunotherapy resistance in colorectal cancerYao Zhang, Xinyu Yang, Zhiyuan Cheng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2017
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trialHongru Yang, Xin Chen, Sheng Lin, et al.
Nature Communications|May 25, 2021
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomicsRen-Bo Ding, Ping Chen, Barani Kumar Rajendran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Shukui Qin, Jianming Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 4, 2021
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast CancerPing Chen, Xu Zhang, Renbo Ding, et al.
Nature Immunology|February 5, 2025
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Pageof 15